Drug Profile
Research programme: bone morphogenetic protein activators - Curis
Alternative Names: BMP activators; BMP agonists; BMP-7 protein; eptotermin alfa analogues; eptotermin alfa mimeticsLatest Information Update: 19 Jan 2011
Price :
$50
*
At a glance
- Originator Curis
- Class Small molecules
- Mechanism of Action Bone morphogenetic protein activators; Intercellular signalling peptide and protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Kidney disorders; Neurological disorders; Vascular disorders
Most Recent Events
- 22 May 2007 This research programme is available for licensing worldwide (http://www.curis.com)
- 19 May 2007 Ortho Biotech Products terminates its worldwide licence to this research programme
- 12 Dec 2005 Curis and Centocor expanded their collaboration agreement to screen and validate small molecule agonists based on Curis' BMP technology portfolio